AbbVie Inc.

NYSE-ABBV

OverviewFinancialsInvestor RelationsResearchEstimatesNewsOwnershipIndustryDividendsModelingFilings

Operating Activities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Net Income	2,395	4,286	4,873	11,845	11,549	4,622	7,882	5,687	5,309	5,953	5,144
Net Earnings
Depreciation & Amortization	8,254	8,386	8,698	8,467	8,521	6,471	2,017	1,765	1,501	1,189	836
Depreciation
Amortization of Intangible Assets
Stock Based Compensation	962	911	747	671	692	753	430	421	365	353	282
Stock-Based Compensation
Other Adjustments	6,212	8,005	5,708	4,054	3,246	5,636	4,446	5,163	2,776	1,235	769
Deferred Income Taxes
Change in Fair Value of Contingent Consideration Liabilities
Payments of Contingent Consideration Liabilities
Acquired IPR&D and Milestones
Devaluation Loss Related to Venezuela
Other Charges Related to Collaborations
Gain on Divestitures
Non-Cash Litigation Reserve Adjustments, Net of Cash Payments
Impairment of Intangible Assets
Impacts Related to U.S. Tax Reform
Other, Net
Changes in Trade Receivables	-1,265	207	66	-1,455	-1,321	-929	-74	-591	-391	-71	-1,076
Accounts Receivable
Changes in Inventories	-337	-319	-417	-686	-142	-40	-231	-226	93	-38	-434
Inventories
Changes in Income Taxes Payable	-3,211	-3,208	-488	542	-1,290	-573	-1,018	674	—	—	—
Income Tax Assets and Liabilities, Net
Changes in Other Operating Activities	2,527	538	3,652	1,505	1,522	1,648	-128	534	307	-1,580	2,014
Prepaid Expenses and Other Assets
Accounts Payable and Other Liabilities
Cash from Operating Activities	20,860	18,806	22,839	24,943	22,777	17,588	13,324	13,427	9,960	7,041	7,535
Cash Flows from Operating Activities

Investing Activities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Capital Expenditure	-1,176	-974	-777	-695	-787	-798	-552	-638	-529	-479	-532
Acquisitions of Property and Equipment
Purchases of Investments	-56	-73	-77	-1,438	-119	-61	-583	-1,792	-2,230	-5,315	-851
Purchases of Investment Securities
Proceeds from Sale of Investments	81	555	55	1,530	98	1,525	2,699	2,160	2,793	2,359	899
Sales and Maturities of Investment Securities
Payments for Business Acquisitions	-5,868	-20,517	-1,223	-794	-1,902	-39,610	-1,135	-736	-308	-2,757	-12,452
Acquisitions and Investments
Acquisitions of Businesses, Net of Cash Acquired
Other Acquisitions and Investments, Net of Cash Acquired
Other Investing Activities	169	189	13	774	366	1,387	167	—	—	118	—
Release of Restricted Funds
Other, Net
Cash from Investing Activities	-7,054	-20,820	-2,009	-623	-2,344	-37,557	596	-1,006	-274	-6,074	-12,936
Cash Flows from Investing Activities

Financing Activities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Issuance of Short-Term Debt	—	5,008	—	—	—	—	—	3,002	—	—	—
Proceeds from Issuance of Other Short-Term Borrowings
Repayments of Short-Term Debt	—	-5,008	—	—	—	—	-3,000	—	—	—	—
Repayments of Other Short-Term Borrowings
Net Issuance / (Repayments) of Short-Term Debt	—	—	—	—	—	—	-3,000	3,002	—	—	—
Issuance of Long-Term Debt	—	16,963	—	2,000	1,000	3,000	31,482	5,963	—	11,627	20,660
Proceeds from Issuance of Long-Term Debt
Repayments of Long-Term Debt	-12,551	-9,613	-4,149	-14,433	-9,414	-5,683	-1,536	-6,035	-25	-6,010	-4,018
Repayments of Long-Term Debt and Finance Lease Obligations
Net Issuance / (Repayments) of Long-Term Debt	-12,551	7,350	-4,149	-12,433	-8,414	-2,683	29,946	-72	-25	5,617	16,642
Issuance of Common Shares	134	214	180	262	244	209	8	73	254	268	155
Proceeds from the Exercise of Stock Options
Repurchases of Common Shares	-1,335	-1,708	-1,972	-1,487	-934	-978	-629	-12,014	-1,410	-6,033	-7,586
Purchases of Treasury Stock
Net Issuance / (Repurchases) of Common Shares	-1,201	-1,494	-1,792	-1,225	-690	-769	-621	-11,941	-1,156	-5,765	-7,431
Common Share Dividends Paid	-11,498	-11,025	-10,539	-10,043	-9,261	-7,716	-6,366	-5,580	-4,107	-3,717	-3,294
Dividends Paid
Other Financing Activities	70	-42	-742	-1,102	-674	-333	-1,251	195	-224	-63	-165
Net Change in Short-Term Borrowings
Net Change in Commercial Paper Borrowings with Original Maturities of Three Months or Less
Debt Issuance Costs
Net Transactions with Abbott Laboratories, Excluding Noncash Items
Payments of Contingent Consideration Liabilities
Other, Net
Cash from Financing Activities	-15,419	-5,211	-17,222	-24,803	-19,039	-11,501	18,708	-14,396	-5,512	-3,928	5,752
Cash Flows from Financing Activities

Free Cash Flow	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Free Cash Flow	19,684	17,832	22,062	24,248	21,990	16,790	12,772	12,789	9,431	6,562	7,003
NOPAT	13,044.1	10,538.5	9,946.4	15,923.1	15,936.9	15,456.1	12,144.8	6,984.8	6,558.1	7,052.4	5,834.5
Levered Free Cash Flow	-4,106	16,051	11,382	8,536	10,952	8,641	34,916	10,726	6,656	10,662	23,670
Unlevered Free Cash Flow	19,101.1	14,961.5	20,614.4	25,056.1	23,760.9	22,164.1	12,232.8	9,093.8	7,930.1	6,144.4	7,718.5
Net Change in Cash	-1,613	-7,225	3,608	-483	1,394	-31,470	32,628	-1,975	4,174	-2,961	351